A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

Researchers say early deep brain stimulation and emerging therapies could reshape expectations for patients diagnosed in the U.S.

PHILADELPHIA, PA - February 11, 2026 - PRESSADVANTAGE - Researchers at Thomas Jefferson University have found that ...

Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to ...

How many people in the United States are living with Parkinson’s Disease? According to statistics provided by the American ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 ...

A new stem cell treatment could offer hope for people living with Parkinson’s - More than 1 million Americans live with the ...

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials ...

Scientists have found a key brain network that’s disrupted by Parkinson’s disease, according to a study published today in ...

Keck Medicine of USC is conducting an early phase clinical trial investigating the safety and effectiveness ...